Transseptal Access Systems Market 2022
Transseptal Access Systems Market is expected to grow on a decent note, i.e. reach US$ 845 Mn at present at a CAGR of 9.4% between 2022-2031. VR-based healthcare solution providers are creating ripples and are expected to continue with the same even in the forecast period. The services include critical procedure simulations, medical training, stroke rehabilitation, non-motor and motor rehabilitation, pain relief, autism care, anxiety reduction, and even battling depression. This would be the case with the healthcare vertical shortly.
Click Here to Get Free Sample Copy of This Report@https://www.persistencemarketresearch.com/samples/18703
As per Persistence Market Research’s latest revised industry analysis, the global transseptal access systems market was worth over US$ 771 Mn in 2020, and is projected to surge at a CAGR of 9.4% over the forecast period (2021-2031).
Surging obese population, increasing elderly population with greater risk of cardiac diseases, and rapid technological advancements in transseptal access systems are key factors contributing to significant increase in their sales. For example, the industry has seen the introduction of advanced technologies such as left atrial appendage occlusion therapy for patients with high risk of stroke due to non-valvular atrial fibrillation (AF). Such developments reduce morbidity and enhance quality of life, as well increase survival rate.
Market players are following several marketing strategies such as increasing sales forces, increasing distribution channel, product launching, and acquisitions.
- In 2012, Cook Medical opened a distribution center in Baesweiler, Germany. This expansion has resulted in increasing penetration in the European market.
- In 2016, Terumo signed an agreement with Abbott Laboratories to acquire Vado Steerable Sheath.
Request For Customization@https://www.persistencemarketresearch.com/request-customization/18703
Key Takeaways from Market Study
- Based on product, transseptal access sheaths are leading with over 86% market share.
- Atrial fibrillation ablation is estimated to dominate the market by application. This segment accounted for approximately 65% share of the market, primarily due to rise in the prevalence of atrial fibrillation.
- Hospitals dominate with a market share of 49%. Incidence of atrial fibrillation-related cases is rising dramatically, which has led to a rise in the adoption of these therapies by various hospitals.
- By region, North America is set to dominate the global transseptal access systems market with a value share of around 33%.
- Europe is slated to be the second-largest market with a value share of 25% during the forecast period.
“Launch of new product lines and continuous improvements in available transseptal access systems have enhanced the safety and efficacy of these systems,” says an analyst of Persistence Market Research.
Click Here to Get this Report@https://www.persistencemarketresearch.com/checkout/18703
Market Competition
New product launches is the winning strategy used by leading manufacturers of transseptal access system. Continuous technological advancements and innovation in transseptal access systems are accountable for intense competition among key players. Several organizations are focusing on new product approvals and launches for transseptal access systems.
- For instance, in Jan 2019, Baylis Medical launched ExpanSure, a transseptal access system that combines dilators and sheaths into a single device, which assists in larger dilation as compared to fixed curve sheaths.
- In 2018, Transseptal Solutions Ltd got U.S. FDA approval for the TSP Crosser Transseptal Access System, which is aimed to deliver steady catheter placing and meticulous access.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the Transseptal Access Systems Market in its latest study, presenting a historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.
About PersistenceMarketResearch:
PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353